Evotec (EVTCY) News Today $3.69 +0.19 (+5.43%) As of 09/16/2025 Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC FilingsBuy This Stock EVTCY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Evotec (OTCMKTS:EVTCY) Stock Crosses Below 50 Day Moving Average - Here's What HappenedAugust 29, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Stock Crosses Below 50-Day Moving Average - Here's WhyAugust 18, 2025 | marketbeat.comEvotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution | EVO Stock NewsAugust 13, 2025 | gurufocus.comEvotec (OTCMKTS:EVTCY) Stock Price Passes Below 50 Day Moving Average - Here's WhyAugust 9, 2025 | marketbeat.comSandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics ...July 30, 2025 | gurufocus.comEvotec (OTCMKTS:EVTCY) Shares Pass Below 50 Day Moving Average - Here's What HappenedJuly 23, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Stock Price Crosses Below Fifty Day Moving Average - Here's What HappenedJuly 15, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Share Price Passes Above Fifty Day Moving Average - Here's What HappenedJuly 5, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Shares Cross Above 50 Day Moving Average - Here's What HappenedJune 27, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Share Price Passes Above Fifty Day Moving Average - What's Next?June 19, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Share Price Crosses Above 50-Day Moving Average - What's Next?June 11, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Stock Price Crosses Above 50 Day Moving Average - Should You Sell?June 3, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Stock Passes Below Two Hundred Day Moving Average - Should You Sell?May 26, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Stock Crosses Above 50-Day Moving Average - Should You Sell?May 18, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Share Price Passes Above 50 Day Moving Average - What's Next?May 10, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Stock Passes Above Fifty Day Moving Average - Should You Sell?May 10, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Share Price Crosses Below 50-Day Moving Average - Time to Sell?April 24, 2025 | marketbeat.comEvotec AG: Strategic Cost Reduction and Just-Evotec Biologics Drive Long-Term Growth Amid Revenue ChallengesApril 17, 2025 | tipranks.comEQS-News: Evotec SE unveils new strategy and provides 2025 guidance bolstered by strong Q4 2024 resultsApril 17, 2025 | markets.businessinsider.comEvotec (OTCMKTS:EVTCY) Stock Price Crosses Below Fifty Day Moving Average - Time to Sell?March 11, 2025 | marketbeat.comEQS-AFR: Evotec SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statementsMarch 5, 2025 | markets.businessinsider.comEvotec SE: Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers SquibbMarch 4, 2025 | finanznachrichten.deEvotec (OTCMKTS:EVTCY) Shares Pass Above 50 Day Moving Average - Here's What HappenedFebruary 22, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Shares Cross Above Fifty Day Moving Average - Here's What HappenedFebruary 5, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Shares Pass Below Fifty Day Moving Average - Should You Sell?January 28, 2025 | marketbeat.comEvotec SE: Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung DiseasesJanuary 22, 2025 | finanznachrichten.deEvotec (OTCMKTS:EVTCY) Stock Crosses Below Two Hundred Day Moving Average - Here's WhyJanuary 18, 2025 | marketbeat.comEvotec (OTCMKTS:EVTCY) Share Price Passes Below 200-Day Moving Average - Time to Sell?January 18, 2025 | marketbeat.comHalozyme withdraws $2.1 billion buyout offer for German drug developer EvotecNovember 24, 2024 | finance.yahoo.comEQS-News: Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market ConditionsNovember 6, 2024 | markets.businessinsider.comEvotec (OTCMKTS:EVTCY) Sets New 1-Year Low - What's Next?October 30, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Sets New 52-Week Low - Here's WhyOctober 21, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Hits New 12-Month Low - Here's What HappenedOctober 14, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Sets New 1-Year Low - Time to Sell?October 8, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Share Price Crosses Below 50 Day Moving Average of $3.70October 1, 2024 | marketbeat.comEvotec SE: Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD Toulouse, FranceSeptember 20, 2024 | finanznachrichten.deEvotec (OTCMKTS:EVTCY) Reaches New 12-Month Low at $3.27September 10, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Reaches New 12-Month Low at $3.66August 30, 2024 | marketbeat.comAnalysts Have Been Trimming Their Evotec SE (ETR:EVT) Price Target After Its Latest ReportAugust 17, 2024 | uk.finance.yahoo.comEvotec SE (NASDAQ:EVO) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.comEvotec SE: Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers SquibbAugust 8, 2024 | finanznachrichten.deEQEvotec SE Appoints Dr Christian Wojczewski as Chief Executive OfficerApril 24, 2024 | finance.yahoo.comEQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive OfficerApril 23, 2024 | markets.businessinsider.comEvotec SE: Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The ClinicMarch 6, 2024 | finanznachrichten.deEvotec SE: Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD TherapiesJanuary 10, 2024 | finanznachrichten.deEvotec, Owkin Anounce A.I.-Powered Collaboration In Oncology, Immunology, And InflammationJanuary 4, 2024 | markets.businessinsider.comEvotec SE (NASDAQ:EVO) Q3 2023 Earnings Call TranscriptNovember 12, 2023 | finance.yahoo.comEQS-News: Evotec SE reports results for the first nine months 2023 and provides corporate updateNovember 8, 2023 | markets.businessinsider.com65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in SingaporeOctober 5, 2023 | finance.yahoo.comEvotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D EconomySeptember 27, 2023 | finance.yahoo.com Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVTCY Media Mentions By Week EVTCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVTCY News Sentiment▼0.000.92▲Average Medical News Sentiment EVTCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVTCY Articles This Week▼00▲EVTCY Articles Average Week Get the Latest News and Ratings for EVTCY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Evotec and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ACLX News Today PCVX News Today KRYS News Today ARWR News Today ACAD News Today ADMA News Today AAPG News Today MTSR News Today LNTH News Today MIRM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:EVTCY) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Evotec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
